Mycophenolate Mofetil: A Pharmacoeconomic Review of its Use in Solid Organ Transplantation

By Young M.   Plosker G.L.  

PharmacoEconomics, Vol. 20, Iss. 10, 2002-01 ,pp. : 675-713

Adis International

Access to resources Recommend Favorite

Mycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability

By Shipkova Maria   Armstrong Victor William   Oellerich Michael   Wieland Eberhard  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 505-526

Informa Healthcare

Access to resources Recommend Favorite

Issues of Adherence to Immunosuppressant Therapy After Solid-Organ Transplantation

By Chisholm M.A.  

Drugs, Vol. 62, Iss. 4, 2002-04 ,pp. : 567-575

Adis International

Access to resources Recommend Favorite

Immunosuppressants: Nephrogenic systemic fibrosis (first report with prednisone, tacrolimus and mycophenolate mofetil) after organ transplantation: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1169, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Management of Cytomegalovirus Infection after Solid-Organ or Stem-Cell Transplantation: Current Guidelines and Future Prospects

By Hebart H.  

Drugs, Vol. 55, Iss. 1, 1998-01 ,pp. : 59-72

Adis International

Access to resources Recommend Favorite